Charles River Laboratories International, Inc.
CRL Healthcare Diagnostics & Research
Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024. In the quarter to June 2026, revenue fell 2.72%, EPS fell 102.8%, free cash flow fell 12.2% and total debt rose 12.3%, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow CRL
Charles River Laboratories International, Inc. (CRL) Gross margin
Charles River Laboratories International, Inc.'s gross margin over the twelve months to 30 June 2026 was 32.7%, down 0.3 percentage points from fiscal 2025 (33.0%). Over the past ten years it has ranged from 32.9% (fiscal 2024) to 39.0% (fiscal 2015); the current reading is higher than 18% of that period. That is below the Diagnostics & Research industry median of 50.9% and below the Healthcare sector median of 53.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 33.0% | 0.08 |
| FY2024 | 32.9% | (3.51) |
| FY2023 | 36.4% | (0.40) |
| FY2022 | 36.8% | (0.91) |
| FY2021 | 37.7% | 0.98 |
| FY2020 | 36.7% | 0.16 |
| FY2019 | 36.6% | (0.51) |
| FY2018 | 37.1% | (0.66) |
| FY2017 | 37.7% | (0.57) |
| FY2016 | 38.3% | (0.66) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 36.2% | 6.60 |
| Mar 2026 | 29.6% | (1.56) |
| Dec 2025 | 31.2% | (2.57) |
| Sep 2025 | 33.7% | (0.87) |
| 42 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| MEDP Medpace Holdings, Inc. compare | 72.4% |
| GH Guardant Health, Inc. compare | 65.0% |
| QGEN QIAGEN N.V. compare | 62.2% |
| RVTY Revvity Inc. compare | 55.0% |
| TWST Twist Bioscience Corporation compare | 52.0% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| CRL Charles River Laboratories International, Inc. | 32.7% |
| LH Labcorp Holdings Inc. compare | 28.9% |
| ICLR ICON PLC compare | 23.9% |
| Diagnostics & Research industry median | 50.9% |
| Healthcare sector median | 53.5% |
| Market median | 46.2% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on CRL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement